| 000 | 01211 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517124802.0 | ||
| 264 | 0 | _c20170417 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a2327-6924 | ||
| 024 | 7 |
_a10.1002/2327-6924.12428 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYoung, Melodie | |
| 245 | 0 | 0 |
_aApremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease. _h[electronic resource] |
| 260 |
_bJournal of the American Association of Nurse Practitioners _cDec 2016 |
||
| 300 |
_a683-695 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNurse Practitioners _xeducation |
| 650 | 0 | 4 |
_aPhosphodiesterase 4 Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 700 | 1 | _aRoebuck, Heather L | |
| 773 | 0 |
_tJournal of the American Association of Nurse Practitioners _gvol. 28 _gno. 12 _gp. 683-695 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/2327-6924.12428 _zAvailable from publisher's website |
| 999 |
_c26624328 _d26624328 |
||